Clinical Trials in Örebro, Sweden
1 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
DESTINY Breast Respond HER2-low Europe
Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 2
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Breast Cancer
Karolinska University Hospital370 enrolled7 locationsNCT05900206
Recruiting
Not Applicable
Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
Neoadjuvant TherapyBreast Cancer Early Stage Breast Cancer (Stage 1-3)Shared Decision Making
Region Örebro County218 enrolled3 locationsNCT06777420
Recruiting
Not Applicable
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Breast Cancer
Region Skane1,350 enrolled26 locationsNCT05634889
Recruiting
Phase 3
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Metastatic Breast CancerAdvanced Breast CancerQuality of Life+2 more
Region Örebro County495 enrolled12 locationsNCT06044623
Recruiting
Phase 3
Use of GnRHa During Chemotherapy for Fertility Protection
Breast Cancer FemaleSoft Tissue SarcomaAcute Leukemia+3 more
Kenny Rodriguez-Wallberg500 enrolled17 locationsNCT05328258